Volume 15, Issue 12, Pages 1361-1368 (November 2014) Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial Amanda Tristram, MD, Christopher N Hurt, MSc, Tracie Madden, PhD, Ned Powell, PhD, Stephen Man, PhD, Sam Hibbitts, PhD, Peter Dutton, MSc, Sadie Jones, MBBCh, Andrew J Nordin, FRCOG, Raj Naik, MD, Prof Alison Fiander, DM, Prof Gareth Griffiths, PhD The Lancet Oncology Volume 15, Issue 12, Pages 1361-1368 (November 2014) DOI: 10.1016/S1470-2045(14)70456-5 Copyright © 2014 Tristram et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure Trial profile The Lancet Oncology 2014 15, 1361-1368DOI: (10.1016/S1470-2045(14)70456-5) Copyright © 2014 Tristram et al. Open Access article distributed under the terms of CC BY Terms and Conditions